SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Clown-Free Zone... sorry, no clowns allowed
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joan Osland Graffius who wrote (78747)3/15/2001 10:20:25 PM
From: Spekulatius   of 436258
 
SANG -
SANG is indeed cheap but so are many other Biotech stocks. I did like the stock in fall at the same price, but since then, many Biotechs have fallen 50-60%,so the relative valuation does not look that great any more.
SANG does have a reasonable revenue stream but the gross margin is not that great. SANG needs to gear up R&D expenses for the GvHD drug ABX-CBL and they are very low on cash.
I do like cash rich Biotech right now and there are so many to choose from: ABGX, NBIX,VRTX,SEPR,INCY,LEXG etc. etc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News